Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 30, 2017 FORM 4 SUBMISSION
4 Jun 30, 2017 FORM 4 SUBMISSION
4 Jun 30, 2017 FORM 4 SUBMISSION
4 Jun 30, 2017 FORM 4 SUBMISSION
4 Jun 30, 2017 FORM 4 SUBMISSION
8-K Jun 30, 2017 8-K
4 Jun 23, 2017 FORM 4 SUBMISSION
CT ORDER Jun 19, 2017
8-K Jun 8, 2017 8-K
10-Q/A Jun 7, 2017 10-Q/A
8-K Jun 5, 2017 8-K
8-K May 24, 2017 FORM 8-K
DEFA14A May 15, 2017 DEFA14A
DEF 14A May 15, 2017 DEF 14A
10-Q May 11, 2017 10-Q
8-K May 10, 2017 FORM 8-K
8-K May 3, 2017 8-K
EFFECT Apr 25, 2017
424B5 Apr 25, 2017 424B5
SC 13G Apr 3, 2017 SCHEDULE 13G
S-3 Mar 31, 2017 S-3
8-K Mar 31, 2017 8-K
8-K/A Mar 31, 2017 8-K/A
8-K Mar 30, 2017 8-K
4 Mar 28, 2017 FORM 4 SUBMISSION
← Newer Page 25 of 33 · 821 filings Older →